For unclear reasons, the efficacy of aromatase inhibitors for treating gynecomastia of various causes appears to be poor or modest at best (206–209), although anastrozole successfully treated two cases of TRT-associated gynecomastia (210). The gene discussed is CYP19A1; the disease is Gynecomastia.